CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Current assets
Cash and cash equivalents	$ 192,606	$ 237,375
Accounts receivable, less allowance for doubtful accounts of $945 and $476	102,396	94,876
Accounts receivable from joint ventures	3,223	1,760
Accounts receivable, other	1,507	1,823
Taxes receivable	1,953	606
Inventories	85,536	68,628
Prepaid income taxes	3,661	4,586
Deferred income taxes	9,878	8,527
Asbestos-related insurance receivables	6,827	6,827
Other current assets	8,423	7,046
Assets held for sale	8,469
Total current assets	424,479	432,054
Property, plant and equipment, net of accumulated depreciation of $234,005 and $225,092	180,145	150,420
Investments in unconsolidated joint ventures	17,938	17,214
Deferred income taxes	13,362	44,853
Pension asset	403	403
Goodwill	177,604	98,227
Other intangible assets	77,577	38,340
Asbestos-related insurance receivables	46,186	46,186
Other long-term assets	6,275	7,420
Total assets	943,969	835,117
Current liabilities
Accounts payable	24,352	20,020
Accrued employee benefits and compensation	21,604	33,983
Accrued income taxes payable	10,049	6,103
Current portion of lease obligation	287	747
Current portion of long term debt	3,094	35,000
Asbestos-related liabilities	6,827	6,827
Other accrued liabilities	20,370	17,765
Liabilities held for sale	1,743
Total current liabilities	88,326	120,445
Long term lease obligation	5,772	6,042
Long term debt	176,219	25,000
Pension liability	13,150	17,652
Retiree health care and life insurance benefits	8,768	8,768
Asbestos-related liabilities	49,718	49,718
Non-current income tax	12,702	10,544
Deferred income taxes	9,889	14,647
Other long-term liabilities	3,298	338
Shareholders’ Equity
Capital Stock - $1 par value; 50,000 authorized shares; 17,982 and 18,404 shares outstanding	17,982	18,404
Additional paid-in capital	112,785	137,225
Retained earnings	531,049	491,428
Accumulated other comprehensive income (loss)	(85,689)	(65,094)
Total shareholders' equity	576,127	581,963
Total liabilities and shareholders' equity	$ 943,969	$ 835,117